[go: up one dir, main page]

DE69732760D1 - Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern - Google Patents

Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Info

Publication number
DE69732760D1
DE69732760D1 DE69732760T DE69732760T DE69732760D1 DE 69732760 D1 DE69732760 D1 DE 69732760D1 DE 69732760 T DE69732760 T DE 69732760T DE 69732760 T DE69732760 T DE 69732760T DE 69732760 D1 DE69732760 D1 DE 69732760D1
Authority
DE
Germany
Prior art keywords
drug
vaginal
core
containing core
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732760T
Other languages
English (en)
Other versions
DE69732760T2 (de
Inventor
Saleh Ismail Saleh
Harold Nash
Wayne Bardin
Troy Harmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of DE69732760D1 publication Critical patent/DE69732760D1/de
Publication of DE69732760T2 publication Critical patent/DE69732760T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
DE69732760T 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern Expired - Lifetime DE69732760T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2379296P 1996-07-31 1996-07-31
US23792P 1996-07-31
US850327 1997-05-02
US08/850,327 US5972372A (en) 1996-07-31 1997-05-02 Intravaginal rings with insertable drug-containing core
PCT/US1997/012777 WO1998004220A1 (en) 1996-07-31 1997-07-22 Intravaginal rings with insertable drug-containing core

Publications (2)

Publication Number Publication Date
DE69732760D1 true DE69732760D1 (de) 2005-04-21
DE69732760T2 DE69732760T2 (de) 2006-04-13

Family

ID=26697614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732760T Expired - Lifetime DE69732760T2 (de) 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Country Status (13)

Country Link
US (2) US5972372A (de)
EP (1) EP0862396B1 (de)
JP (1) JP3970936B2 (de)
CN (1) CN1154455C (de)
AT (1) ATE290836T1 (de)
AU (1) AU4043197A (de)
BR (1) BR9706802A (de)
CA (1) CA2232635C (de)
DE (1) DE69732760T2 (de)
DK (1) DK0862396T3 (de)
ES (1) ES2239363T3 (de)
PT (1) PT862396E (de)
WO (1) WO1998004220A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537566B1 (en) 1999-03-11 2003-03-25 John Alton Copland Compositions and methods for the non-invasive treatment of uterine fibroid cells
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
KR20040036928A (ko) * 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
ES2388731T5 (es) * 2002-03-27 2018-01-19 Warner Chilcott (Ireland) Limited Dispositivos de administración de fármacos mediante una matriz intravaginal
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CA2531640C (en) * 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
MX2007000273A (es) * 2004-07-09 2007-05-21 Population Council Inc Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
CA2615393C (en) 2005-07-19 2011-09-20 The Population Council, Inc. Methods and compositions for emergency contraception using endothelin receptor antagonists
WO2007021964A2 (en) 2005-08-11 2007-02-22 Massachusetts Institute Of Technology Intravesical drug delivery device and method
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
EP2001350A4 (de) * 2006-03-20 2013-04-17 Teva Womens Health Inc Flexible komprimierte intravaginale ringe, verfahren zu ihrer herstellung und verwendung sowie gerät für ihre herstellung
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
RU2444364C2 (ru) * 2006-07-12 2012-03-10 Контроллд Терапьютикс (Скотлэнд) Лтд. Полимер для доставки лекарств с гидрохлоридной солью клиндамицина
US20080045560A1 (en) * 2006-08-15 2008-02-21 Wyeth Pyrrolidine and related derivatives useful as PR modulators
WO2008021338A2 (en) * 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7652018B2 (en) * 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US20100316691A2 (en) * 2007-01-19 2010-12-16 University Of Utah Research Foundation Biodegradable intravaginal medical device for delivery of therapeutics
EP3470055A1 (de) 2007-06-26 2019-04-17 Allergan Pharmaceuticals International Limited Vorrichtungen zur intravaginalen ausgabe von makromolekülen und wasserlöslichen arzneimitteln
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
PT2062569E (pt) * 2007-11-22 2011-07-25 Bayer Oy Sistema de administração vaginal
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
SI2249757T1 (sl) 2008-02-04 2017-10-30 Ferring B.V. Monolitni intravaginalni obroč, ki vsebuje progesteron ter postopki za njegovo izdelavo in uporabo
CA2733468C (en) 2008-08-09 2017-12-05 Massachusetts Institute Of Technology Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US20120070476A1 (en) * 2009-05-29 2012-03-22 Moench Thomas R Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
CN104887388B (zh) 2009-06-03 2018-01-09 弗赛特影像5股份有限公司 前段药物输送
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
US8753667B2 (en) * 2009-07-21 2014-06-17 The Population Council, Inc. Multi-layered gradient vaginal ring
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US20130096092A1 (en) 2010-06-10 2013-04-18 Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
MX2013000003A (es) * 2010-06-22 2013-04-29 Teva Womens Health Inc Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos.
CA2808276A1 (en) 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CA2817713C (en) 2010-11-12 2018-12-04 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
SG191893A1 (en) 2011-01-10 2013-08-30 Taris Biomedical Inc Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) * 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
CA2838402C (en) 2011-06-06 2019-12-03 Oak Crest Institute Of Science Drug delivery device employing wicking release window
EP2749286B1 (de) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Verwendung der nichtsteroidalen entzündungshemmer meloxicam und piroxicam in intravaginalringen zur unterbrechung des eisprungs bei frauen
RU2618194C2 (ru) 2011-09-14 2017-05-02 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
WO2013078422A2 (en) 2011-11-23 2013-05-30 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
TW201332585A (zh) * 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
EP2641602A1 (de) 2012-03-23 2013-09-25 PregLem S.A. Verfahren zur Behandlung gynäkologischer Leiden
DE102012009057A1 (de) * 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2674654T3 (es) 2012-09-03 2018-07-03 Ecosea Farming S.A. Sistema de inmersión de jaulas de depósito para el cultivo y/o contención de especies hidrobiológicas
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014123880A1 (en) 2013-02-05 2014-08-14 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
HUE049219T2 (hu) * 2013-02-08 2020-09-28 Qpharma Ab Intravaginális eszköz, valamint eljárás az intravaginális eszközben lévõ hatóanyag diffúziós sebességének csökkentésére
JP7078345B2 (ja) * 2013-03-08 2022-05-31 リ・ガリ・ベスローテン・フエンノートシャップ 膣内薬剤送達および／または膣内診断を行なうシステム
CA2903164C (en) 2013-03-15 2024-06-11 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
AR095831A1 (es) 2013-04-10 2015-11-11 Preglem Sa Moduladores de los receptores de progesterona útiles en la terapia de los fibroides uterinos
CA2919215C (en) 2013-08-19 2022-11-29 Taris Biomedical Llc Multi-unit drug delivery devices and methods
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3079659B1 (de) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Arzneimittelliefersystem zur verabreichung von virenbekämpfungsmitteln
AU2015211356B2 (en) 2014-01-28 2020-04-16 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
LT3125964T (lt) * 2014-04-01 2024-09-25 Poly-Med Inc. Kontraceptikas ir atitinkama priemonė
US20150306230A1 (en) * 2014-04-28 2015-10-29 Celanese Acetate Llc Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2873222A1 (en) * 2014-06-28 2015-12-28 German Arzobindo Campos Perez Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3435977A4 (de) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Pharmazeutische steroidhormonzusammensetzung
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
WO2019084469A1 (en) 2017-10-27 2019-05-02 Renovia Inc. DEVICES, SYSTEMS, AND METHODS FOR PELVIC FLOOR MUSCLE TRAINING
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) * 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
CN114980861A (zh) * 2019-11-27 2022-08-30 橡冠科学研究院 缓释药物递送装置
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US3995633A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3991760A (en) * 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
JPS5339064U (de) * 1976-09-08 1978-04-05
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) * 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
DE69732760T2 (de) 2006-04-13
MX9802349A (es) 1998-08-30
US5972372A (en) 1999-10-26
AU4043197A (en) 1998-02-20
CN1198091A (zh) 1998-11-04
CN1154455C (zh) 2004-06-23
ES2239363T3 (es) 2005-09-16
JP3970936B2 (ja) 2007-09-05
WO1998004220A1 (en) 1998-02-05
JPH11512965A (ja) 1999-11-09
BR9706802A (pt) 1999-08-31
PT862396E (pt) 2005-07-29
CA2232635A1 (en) 1998-02-05
ATE290836T1 (de) 2005-04-15
CA2232635C (en) 2002-09-17
US6126958A (en) 2000-10-03
DK0862396T3 (da) 2005-07-11
EP0862396A4 (de) 2000-09-06
EP0862396A1 (de) 1998-09-09
EP0862396B1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
DE69732760D1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
KR100312764B1 (ko) 질내전달시스템
US4186742A (en) Contraceptive-antivenereal disease tampon
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
CA2119252A1 (en) Controlled porosity implantable primary lumen device
BRPI0015284B8 (pt) formulações de hidrocodona de liberação controlada
CA2222133A1 (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
IE860306L (en) Drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CA2233753A1 (en) Drug delivery system for two or more active substances
CA2292402A1 (en) Intra-vaginal device for pigs
SE8803087D0 (sv) A new method of treating erectile dysfunction
CA2040914A1 (en) Treatment of erectile dysfunction
WO1998004220A9 (en) Intravaginal rings with insertable drug-containing core
CA2181742A1 (en) Reduction of skin irritation during electrotransport delivery
CA2188907A1 (en) Combination compound for contraception based on natural estrogen
WO2000042942A3 (en) Buccal drug delivery system for use in male contraception
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
IE801903L (en) Drug delivery device
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
MY124465A (en) Reduction of infarct volume using citicoline
EP0873751A3 (de) Pharmazeutisches produkt zur anwendung auf der mukosa der gebärmutter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition